1. soccerbooters
2. joeholidaybuys
3. djbenmacias
4. candiskingdom
5. bugbeas499315
1.toonses85 02/14/2018
end at low of day, not good
2.feruizdeluna 07/30/2018
Beats EPS loss estimates by $0.01. Misses on revenues.
3.joeholidaybuys 06/25/2018
Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem1 Study Presented at ADA 2018 and Published in Diabetes Care
4.soccerbooters 05/04/2018
new XERMELO data from the Phase 3 TELESTAR study in Clinical Therapeutics
5.djbenmacias 03/29/2018
Lexicon Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application (MAA) for Sotagliflozin to Treat Adults With Type 1 Diabetes
6.candiskingdom 02/26/2018
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update
7.soccerbooters 02/14/2018
8.09 now {Image}
8.candiskingdom 02/14/2018
Scared to hold to be honest
9.bugbeas499315 02/14/2018
JPMorgan cuts to underweight, $10PT
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW